Policy Statement

Cellulogix International is committed to supporting basic and clinical scientific research to alleviate the burden of human suffering caused by various illnesses. For many of these diseases or conditions, symptoms and suffering are directly caused by the destruction of cells and tissues that the adult human body cannot regenerate. In these situations, as well as in many others, future cures will almost certainly involve replacing the destroyed tissue or cells, and Cellulogix International is committed to all avenues of research that lead to this goal. Any less effort would be a disservice to our many supporters, the millions of victims suffering from these conditions, and their families. Therefore, Cellulogix International supports research to translate the promise of human cord blood stem cell research into treatments and cures for millions of individuals suffering from devastating diseases. We support the ethical derivation and use of human Pluripotent stem cells in research. We believe that it is our responsibility to make sure that the men, women, and children who are suffering from life-threatening diseases benefit as quickly as possible from the very best that science and technology has to offer.

Cellulogix International does not support reproductive cloning of human beings. We recognize that these are complex issues that engender strong opinions. Indeed, it is impossible for any person or organization to adopt a policy on this subject that will not be in opposition to some opinions and feelings. However, the enormous potential benefit to be derived from this new area of research, and the clear relevance of these benefits to our mission, compel us to join with the broad scientific and patient advocacy communities in supporting the careful and ethical derivation and use of human Pluripotent stem cells in scientific research.

Copyright Statement

Material presented on all pages of this website are intended to be used to inform individuals who visit this website.  The text, videos and all material in this website are copyrighted and are considered to be properties of Dr. Casey Nabavi. These materials may not be copied and/or distributed without the written consent of Dr. Casey Nabavi. Violators will be prosecuted.

Industry News

Stanford University Awarded over $5M for Research

Stanford University Medical Center. Four researchers at the Stanford University School of Medicine have been awarded just over $5.5 million for their stem cell research projects.
The California Institute for Regenerative Medicine is now funding projects that are attempting to find ways to overcome immune system rejection of transplanted stem cells. The institute is the state [...]

Read More

Patient Shares Comments Re: His Progress Since Treatment for Ataxia

Dear Cellulogix:   I’m Phil D. and I had my transplant the week of May 5th 2009.  We have communicated several times in the past but not lately. I had my 13th month post transplant exam with my Neurologist yesterday June 18th and thought Dr.Nabavi and you would be interested in an update on my condition. [...]

Read More

New Stem Cell Center At UC Irvine

Hub of hope and healing
Dedication of UCI’s Gross Hall is milestone in effort to unlock stem cells’ potential
 Daniel A. Anderson / University Communications
The May 14 dedication of UCI’s Sue & Bill Gross Hall: A CIRM Institute was a milestone in the effort to unlock stem cells’ potential. Here, CIRM fellows are briefed before leading guest [...]

Read More

Need to Send Medical Records?

Cellulogix recently added the Doc’s@cellulogix email address for our patients to send in their medical reports and all other pertinent information that may be requested. This is helpful if you want our team of specialists to have your medical information prior to your initial consultation as well as follow up reports that are requested.

Read More